Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (6), assessment of mandibular metabolism due to long-term administration of an anti-resorptive agent by bone scintigraphy (secondary publication)

Summary: It is not yet known why anti-resorptive agent-related osteonecrosis specifically affects the jaw. Here we assessed changes in the bone metabolism of the mandible in response to long-term bisphosphonate (BP) therapy, and we compared the bone metabolism changes of the mandible with those of o...

Full description

Bibliographic Details
Main Authors: Yumiko Ohbayashi, Fumi Nakai, Akinori Iwasaki, Takaaki Ogawa, Yuka Yamamoto, Yoshihiro Nishiyama, Minoru Miyake
Format: Article
Language:English
Published: Elsevier 2019-11-01
Series:Japanese Dental Science Review
Online Access:http://www.sciencedirect.com/science/article/pii/S1882761618301029
_version_ 1819238338177007616
author Yumiko Ohbayashi
Fumi Nakai
Akinori Iwasaki
Takaaki Ogawa
Yuka Yamamoto
Yoshihiro Nishiyama
Minoru Miyake
author_facet Yumiko Ohbayashi
Fumi Nakai
Akinori Iwasaki
Takaaki Ogawa
Yuka Yamamoto
Yoshihiro Nishiyama
Minoru Miyake
author_sort Yumiko Ohbayashi
collection DOAJ
description Summary: It is not yet known why anti-resorptive agent-related osteonecrosis specifically affects the jaw. Here we assessed changes in the bone metabolism of the mandible in response to long-term bisphosphonate (BP) therapy, and we compared the bone metabolism changes of the mandible with those of other bone sites using a quantitative analysis by bone scintigraphy. The region of interest was selected by identifying without an abnormal accumulation of the mandible, humerus, second and fourth lumbar vertebrae, iliac crest, intertrochanteric femur and diaphysis. Bone scintigraphy images were quantified using a value we termed the ‘bone uptake value (BUV)’. In the low-dose bisphosphonate (LBP) group (n = 21), the patients were undergoing osteoporosis treatment with low-dose BP. The high-dose BP (HBP) group consisted of 12 bone metastasis patients undergoing high-dose BP treatment. The Control group was 47 subjects with oral disease who had never been treated with an anti-resorptive agent. Our analyses demonstrated that with long-term BP administration, the bone metabolism of the iliac crest and intertrochanteric femur was suppressed but that of the mandible was enhanced. There was no significant difference in bone metabolism with either the low-dose BP or high-dose BP treatment. The effects of the long-term administration of BP were site-specific. Keywords: Mandibular metabolism, Long-term, BP, Anti-resorptive agent, Bone scintigraphy, Jaw
first_indexed 2024-12-23T13:34:38Z
format Article
id doaj.art-1f872d3ae23a41fca540d32fdb956798
institution Directory Open Access Journal
issn 1882-7616
language English
last_indexed 2024-12-23T13:34:38Z
publishDate 2019-11-01
publisher Elsevier
record_format Article
series Japanese Dental Science Review
spelling doaj.art-1f872d3ae23a41fca540d32fdb9567982022-12-21T17:45:03ZengElsevierJapanese Dental Science Review1882-76162019-11-015515157Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (6), assessment of mandibular metabolism due to long-term administration of an anti-resorptive agent by bone scintigraphy (secondary publication)Yumiko Ohbayashi0Fumi Nakai1Akinori Iwasaki2Takaaki Ogawa3Yuka Yamamoto4Yoshihiro Nishiyama5Minoru Miyake6Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Kagawa University, Kagawa, Japan; Corresponding author. Present/permanent address: Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa 761-0793, Japan.Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Kagawa University, Kagawa, JapanDepartment of Oral and Maxillofacial Surgery, Faculty of Medicine, Kagawa University, Kagawa, JapanDepartment of Oral and Maxillofacial Surgery, Faculty of Medicine, Kagawa University, Kagawa, JapanDepartment of Radiology, Faculty of Medicine, Kagawa University, Kagawa, JapanDepartment of Radiology, Faculty of Medicine, Kagawa University, Kagawa, JapanDepartment of Oral and Maxillofacial Surgery, Faculty of Medicine, Kagawa University, Kagawa, JapanSummary: It is not yet known why anti-resorptive agent-related osteonecrosis specifically affects the jaw. Here we assessed changes in the bone metabolism of the mandible in response to long-term bisphosphonate (BP) therapy, and we compared the bone metabolism changes of the mandible with those of other bone sites using a quantitative analysis by bone scintigraphy. The region of interest was selected by identifying without an abnormal accumulation of the mandible, humerus, second and fourth lumbar vertebrae, iliac crest, intertrochanteric femur and diaphysis. Bone scintigraphy images were quantified using a value we termed the ‘bone uptake value (BUV)’. In the low-dose bisphosphonate (LBP) group (n = 21), the patients were undergoing osteoporosis treatment with low-dose BP. The high-dose BP (HBP) group consisted of 12 bone metastasis patients undergoing high-dose BP treatment. The Control group was 47 subjects with oral disease who had never been treated with an anti-resorptive agent. Our analyses demonstrated that with long-term BP administration, the bone metabolism of the iliac crest and intertrochanteric femur was suppressed but that of the mandible was enhanced. There was no significant difference in bone metabolism with either the low-dose BP or high-dose BP treatment. The effects of the long-term administration of BP were site-specific. Keywords: Mandibular metabolism, Long-term, BP, Anti-resorptive agent, Bone scintigraphy, Jawhttp://www.sciencedirect.com/science/article/pii/S1882761618301029
spellingShingle Yumiko Ohbayashi
Fumi Nakai
Akinori Iwasaki
Takaaki Ogawa
Yuka Yamamoto
Yoshihiro Nishiyama
Minoru Miyake
Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (6), assessment of mandibular metabolism due to long-term administration of an anti-resorptive agent by bone scintigraphy (secondary publication)
Japanese Dental Science Review
title Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (6), assessment of mandibular metabolism due to long-term administration of an anti-resorptive agent by bone scintigraphy (secondary publication)
title_full Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (6), assessment of mandibular metabolism due to long-term administration of an anti-resorptive agent by bone scintigraphy (secondary publication)
title_fullStr Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (6), assessment of mandibular metabolism due to long-term administration of an anti-resorptive agent by bone scintigraphy (secondary publication)
title_full_unstemmed Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (6), assessment of mandibular metabolism due to long-term administration of an anti-resorptive agent by bone scintigraphy (secondary publication)
title_short Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (6), assessment of mandibular metabolism due to long-term administration of an anti-resorptive agent by bone scintigraphy (secondary publication)
title_sort symposium imaging modalities for drug related osteonecrosis of the jaw 6 assessment of mandibular metabolism due to long term administration of an anti resorptive agent by bone scintigraphy secondary publication
url http://www.sciencedirect.com/science/article/pii/S1882761618301029
work_keys_str_mv AT yumikoohbayashi symposiumimagingmodalitiesfordrugrelatedosteonecrosisofthejaw6assessmentofmandibularmetabolismduetolongtermadministrationofanantiresorptiveagentbybonescintigraphysecondarypublication
AT fuminakai symposiumimagingmodalitiesfordrugrelatedosteonecrosisofthejaw6assessmentofmandibularmetabolismduetolongtermadministrationofanantiresorptiveagentbybonescintigraphysecondarypublication
AT akinoriiwasaki symposiumimagingmodalitiesfordrugrelatedosteonecrosisofthejaw6assessmentofmandibularmetabolismduetolongtermadministrationofanantiresorptiveagentbybonescintigraphysecondarypublication
AT takaakiogawa symposiumimagingmodalitiesfordrugrelatedosteonecrosisofthejaw6assessmentofmandibularmetabolismduetolongtermadministrationofanantiresorptiveagentbybonescintigraphysecondarypublication
AT yukayamamoto symposiumimagingmodalitiesfordrugrelatedosteonecrosisofthejaw6assessmentofmandibularmetabolismduetolongtermadministrationofanantiresorptiveagentbybonescintigraphysecondarypublication
AT yoshihironishiyama symposiumimagingmodalitiesfordrugrelatedosteonecrosisofthejaw6assessmentofmandibularmetabolismduetolongtermadministrationofanantiresorptiveagentbybonescintigraphysecondarypublication
AT minorumiyake symposiumimagingmodalitiesfordrugrelatedosteonecrosisofthejaw6assessmentofmandibularmetabolismduetolongtermadministrationofanantiresorptiveagentbybonescintigraphysecondarypublication